HCW Biologics (HCWB) Net Cash Flow (2020 - 2025)
HCW Biologics' (HCWB) quarterly Net Cash Flow came in at $855555.0 in Q4 2025, down 76.73% YoY from $3.7 million in Q4 2024, and up 163.75% on a QoQ basis from -$1.3 million in Q3 2025.
HCW Biologics (HCWB) Net Cash Flow (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Net Cash Flow data on file, last reported at $855555.0 in Q4 2025.
- Quarterly Net Cash Flow fell 76.73% year-over-year to $855555.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.7 million (down 352.17% YoY) and the FY2025 annual result came in at -$2.7 million, down 352.17% from the prior year.
- Net Cash Flow improved to $855555.0 in Q4 2025, from -$1.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $95.1 million in Q4 2021 to a low of -$88.5 million in Q3 2021.
- A 5-year average of -$325168.5 and a median of -$1.5 million in 2021 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 4721.66% in 2021, down 2768.75% in 2021.
- Tracing HCWB's Net Cash Flow over 5 years: stood at $95.1 million in 2021, then slumped by 104.1% to -$3.9 million in 2022, then plunged by 95.64% to -$7.6 million in 2023, then jumped by 148.21% to $3.7 million in 2024, then plunged by 76.73% to $855555.0 in 2025.
- The last three Net Cash Flow figures came in at $855555.0 (Q4 2025), -$1.3 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 855,555.00 |
| Dec 31, 2025 | 855,555.00 |
| Sep 30, 2025 | -1.34 Mn |
| Sep 30, 2025 | -1.34 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | -3.57 Mn |
| Mar 31, 2025 | -3.57 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | -163,093.00 |
| Sep 30, 2024 | -163,093.00 |
| Jun 30, 2024 | -2.92 Mn |
| Jun 30, 2024 | -2.92 Mn |
| Mar 31, 2024 | 488,975.00 |
| Mar 31, 2024 | 488,975.00 |
| Dec 31, 2023 | -7.63 Mn |
| Dec 31, 2023 | -7.63 Mn |
| Sep 30, 2023 | 3.77 Mn |
| Sep 30, 2023 | 3.77 Mn |